Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-26 @ 9:04 AM
Study NCT ID:
NCT00853892
Status:
COMPLETED
Last Update Posted:
2016-09-09
First Post:
2009-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
Sponsor:
Mallinckrodt
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0595-05-812
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Herbert Neuman, MD/Chief Medical Officer
Old Organization:
Mallinckrodt